(2,6-Dimethylpiperidin-1-yl)(5-(4-methoxyphenyl)isoxazol-3-yl)methanone
98%
- Product Code: 129728
CAS:
912777-95-8
Molecular Weight: | 314.38 g./mol | Molecular Formula: | C₁₈H₂₂N₂O₃ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | 507.0±45.0 °C(Predicted) | |
Density: | 1.123±0.06 g/cm3(Predicted) | Storage Condition: | Room temperature, seal, dry |
Product Description:
Used in pharmaceutical research as a synthetic intermediate for developing central nervous system agents. Shows potential in the design of compounds targeting neurological disorders due to its structural affinity for modulating ion channels and receptors. Its derivatives are explored for analgesic and antiarrhythmic properties. Also employed in medicinal chemistry for structure-activity relationship studies owing to its conformationally restricted piperidine core and isoxazole moiety.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
0.010 | 10-20 days | $631.53 |
+
-
|
0.025 | 10-20 days | $1,199.83 |
+
-
|
(2,6-Dimethylpiperidin-1-yl)(5-(4-methoxyphenyl)isoxazol-3-yl)methanone
Used in pharmaceutical research as a synthetic intermediate for developing central nervous system agents. Shows potential in the design of compounds targeting neurological disorders due to its structural affinity for modulating ion channels and receptors. Its derivatives are explored for analgesic and antiarrhythmic properties. Also employed in medicinal chemistry for structure-activity relationship studies owing to its conformationally restricted piperidine core and isoxazole moiety.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :